72: Treatment outcomes with tyrosine kinase inhibitors in patients with uncommon EGFR mutations in non-small cell lung cancer

@inproceedings{Hunter201772TO,
  title={72: Treatment outcomes with tyrosine kinase inhibitors in patients with uncommon EGFR mutations in non-small cell lung cancer},
  author={Sarah Hunter and Guillermina Nickless and Sue Ghosh and Rohit Lal and Scott Merrick and A. Montes and Denis Smith and James Spicer and E. Karapanagiotou},
  year={2017}
}

Topics from this paper.